-
公开(公告)号:US20100204162A1
公开(公告)日:2010-08-12
申请号:US12666279
申请日:2008-06-26
IPC分类号: A61K31/7068 , A61K31/713 , A61K31/225 , A61K31/198 , A61K31/42 , A61K31/52 , A61K31/5375 , A61K31/40 , A61K31/708 , A61K31/7072 , A61K31/58 , A61K31/662 , A61K31/575 , A61K31/5685 , A61P3/00 , A61P17/00 , A61P25/28
CPC分类号: C07J43/003 , A61K31/195 , A61K31/197 , A61K31/40 , A61K31/42 , A61K31/431 , A61K31/445 , A61K31/513 , A61K31/52 , A61K31/5375 , A61K31/575 , A61K31/58 , A61K31/661 , A61K31/6615 , A61K31/675 , A61K31/685 , A61K31/7008 , A61K31/7012 , A61K31/7072 , A61K31/708 , C07D211/94 , C07D473/16 , C07H19/06 , C07H19/20 , C07J7/009
摘要: The present invention provides a compound which is an inhibitor of sphingolipid biosynthesis for use in the treatment of a disease which has a secondary Niemann-Pick type C disease like cellular phenotype.
摘要翻译: 本发明提供了一种化合物,其是鞘脂生物合成抑制剂,其用于治疗具有次级尼曼 - 皮克型C型疾病如细胞表型的疾病。